Literature DB >> 10584668

Progression of falls in postmortem-confirmed parkinsonian disorders.

G K Wenning1, G Ebersbach, M Verny, K R Chaudhuri, K Jellinger, A McKee, W Poewe, I Litvan.   

Abstract

Although falls are known to occur in several parkinsonian disorders, such as Parkinson's disease (PD), multiple system atrophy (MSA), dementia with Lewy bodies (DLB), corticobasal degeneration (CBD), and progressive supranuclear palsy (PSP), differences in the evolution of this feature have not been studied systematically in pathologically confirmed cases. Seventy-seven cases with pathologically confirmed parkinsonian disorders (PD: n = 11, MSA: n = 15, DLB: n = 14, CBD: n = 13, PSP: n = 24), collected up to 1994, formed the basis for a multicenter clinicopathologic study organized by the National Institute of Neurological Disorders and Stroke to improve differential diagnosis of parkinsonian disorders. In the present study, we determined the time course, that is, the duration from first symptom to onset (latency) and duration from onset to death, of recurrent falls. Furthermore, we analyzed the diagnostic validity of a predefined latency to onset of recurrent falls within 1 year of symptom onset. Significant group differences for latency, but not duration, of recurrent falls were observed. Latencies to onset of falls were short in PSP patients, intermediate in MSA, DLB, and CBD, and long in PD. Recurrent falls occurring within the first year after disease onset predicted PSP in 68% of the patients. Our study demonstrates for the first time that latency to onset, but not duration, of recurrent falls differentiates PD from other parkinsonian disorders. Whereas early falls are important for the diagnosis of PSP, the addition of other features increases its diagnostic predictive value.

Entities:  

Mesh:

Year:  1999        PMID: 10584668     DOI: 10.1002/1531-8257(199911)14:6<947::aid-mds1006>3.0.co;2-o

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  18 in total

Review 1.  Multiple system atrophy: pathophysiology and management.

Authors:  G K Wenning; S Braune
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

2.  Predictors of falls and fractures in bradykinetic rigid syndromes: a retrospective study.

Authors:  D R Williams; H C Watt; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-04       Impact factor: 10.154

3.  Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.

Authors:  Martijn L T M Müller; Roger L Albin; Vikas Kotagal; Robert A Koeppe; Peter J H Scott; Kirk A Frey; Nicolaas I Bohnen
Journal:  Brain       Date:  2013-09-20       Impact factor: 13.501

Review 4.  Normal and pathological gait: what we learn from Parkinson's disease.

Authors:  David Grabli; Carine Karachi; Marie-Laure Welter; Brian Lau; Etienne C Hirsch; Marie Vidailhet; Chantal François
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-06-29       Impact factor: 10.154

Review 5.  Reassessment of the role of the central cholinergic system.

Authors:  Anna Hrabovska; Eric Krejci
Journal:  J Mol Neurosci       Date:  2013-11-10       Impact factor: 3.444

6.  Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.

Authors:  Thomas Gerald Beach; Charles H Adler; Lucia I Sue; Jeffrey B Peirce; Jyothi Bachalakuri; Jessica E Dalsing-Hernandez; Lih Fen Lue; John N Caviness; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2007-11-06       Impact factor: 17.088

7.  Recent advances in the assessment and treatment of falls in Parkinson's disease.

Authors:  Anke H Snijders; Jorik Nonnekes; Bastiaan R Bloem
Journal:  F1000 Med Rep       Date:  2010-10-21

Review 8.  Neurological disorders of gait, balance and posture: a sign-based approach.

Authors:  Jorik Nonnekes; Rianne J M Goselink; Evžen Růžička; Alfonso Fasano; John G Nutt; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2018-01-29       Impact factor: 42.937

9.  Dopaminergic medication does not improve stepping responses following backward and forward balance perturbations in patients with Parkinson's disease.

Authors:  Digna de Kam; Jorik Nonnekes; Lars B Oude Nijhuis; Alexander C H Geurts; Bastiaan R Bloem; Vivian Weerdesteyn
Journal:  J Neurol       Date:  2014-09-17       Impact factor: 4.849

Review 10.  Cholinergic dysfunction in Parkinson's disease.

Authors:  Martijn L T M Müller; Nicolaas I Bohnen
Journal:  Curr Neurol Neurosci Rep       Date:  2013-09       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.